CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA

被引：0
|
作者：
Brouwer, W. P. [1 ]
Sonneveld, M. J. [1 ]
Xie, Q. [2 ]
Zhang, N. [3 ]
Zeuzem, S. [4 ]
Tabak, F. [5 ]
Zhang, Q. [6 ]
Simon, K. [7 ]
Akarca, U. S. [8 ]
Streinu-Cercel, A. [9 ]
Hansen, B. [1 ]
Janssen, H. L. [10 ]
机构：
[1] Erasmus MC, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Jiao Tong Univ, Ruijin Hosp, Gastroenterol & Hepatol, Infect Dis, Shanghai 200030, Peoples R China
[3] Fudan Univ, Zhong Shan Hosp, Gastroenterol & Hepatol, Shanghai 200433, Peoples R China
[4] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Gastroenterol & Hepatol, Frankfurt, Germany
[5] Cerrahpasa Med Fac, Gastroenterol & Hepatol, Istanbul, Turkey
[6] Fudan Univ, Shanghai Publ Hlth Ctr, Gastroenterol & Hepatol, Shanghai 200433, Peoples R China
[7] Wroclaw Med Univ, Gastroenterol & Hepatol, Wroclaw, Poland
[8] Ege Univ, Tip Fak, Gastroenterol & Hepatol, Bornova, Turkey
[9] Natl Inst Infect Dis, Gastroenterol & Hepatol, Bucharest, Romania
[10] Toronto Western & Gen Hosp, Univ Hlth Network, Ctr Liver Dis, Gastroenterol & Hepatol, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30873-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0669
引用
收藏
页码：S572 / S573
页数：2
相关论文
共 50 条
  • [21] New treatment strategy: switching from long-term entecavir to peginterferon alfa-2a induces HBeAg seroconversion/HBsAg clearance in patients with HBeAg-positive chronic hepatitis B
    Ning, Qin
    Han, Meifang
    Sun, Yongtao
    Jiang, Jia-ji
    Tan, Deming
    Hou, Jinlin
    Tang, Hong
    Sheng, Jifang
    Zhao, Mianzhi
    HEPATOLOGY, 2012, 56 : 300A - 301A
  • [22] VIROLOGICAL RESPONSE AT 12 WEEKS OF ENTECAVIR THERAPY PREDICTS HBeAg CLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Song, B. -C
    Chae, H. B.
    Kim, Y. N.
    Lee, B. S.
    Cho, Y. -K
    JOURNAL OF HEPATOLOGY, 2009, 50 : S237 - S237
  • [23] Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study
    Dai, Chia-Yen
    Tseng, Tai-Chung
    Wong, Grace Lai Hung
    Huang, Jee-Fu
    Wong, Vincent Wai Sun
    Liu, Chun-Jen
    Yu, Ming-Lung
    Chuang, Wan-Long
    Kao, Jia-Horng
    Chan, Henry Lik Yuen
    Chen, Ding-Shinn
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2332 - 2338
  • [24] HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients
    Jiezuan Yang
    Jiajia Chen
    Ping Ye
    Linfeng Jin
    Wei Wu
    Guoping Sheng
    Lan-Juan Li
    Journal of Translational Medicine, 12
  • [25] HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients
    Yang, Jiezuan
    Chen, Jiajia
    Ye, Ping
    Jin, Linfeng
    Wu, Wei
    Sheng, Guoping
    Li, Lan-Juan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [26] Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients
    Brouwer, W. P.
    Sonneveld, M. J.
    Xie, Q.
    Guo, S.
    Zhang, N.
    Zeuzem, S.
    Tabak, F.
    Zhang, Q.
    Simon, K.
    Akarca, U. S.
    Streinu-Cercel, A.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (06) : 419 - 426
  • [27] ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
    Lau, G. K. K.
    Marcellin, P.
    Brunetto, M.
    Piratvisuth, T.
    Kapprell, H. -P
    Messinger, D.
    Popescu, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S333 - S333
  • [28] Serum HBsAg Levels During Peginterferon α-2a Treatment With or Without Thymosin α-1 in HBeAg-Positive Chronic Hepatitis B Patients
    Song, Eun Young
    Shin, Yunsu
    Roh, Eun Youn
    Sue, Shin
    Park, Myoung Hee
    Kim, Bo Hyun
    Kim, Won
    Yoon, Jung-Hwan
    Lee, Youn-Jae
    Park, Sung Jae
    Jung, Eun Uk
    Lee, Jeong-Hoon
    Myung, Sun Jung
    Kim, Yoon-Jun
    Lee, Hyo-Suk
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (01) : 88 - 94
  • [29] Association between KIR Genes and Efficacy of Treatment of HBeAg-Positive Chronic Hepatitis B Patients with Entecavir
    Zhuang, Yun-Long
    Li, Xi-Xi
    Xu, Hui-Cong
    Ye, Hui
    Sun, Di
    Liu, Xiang-Zhong
    Ren, Gui-Jie
    IRANIAN JOURNAL OF IMMUNOLOGY, 2018, 15 (02) : 112 - 121
  • [30] COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
    Sheng, F.
    VALUE IN HEALTH, 2009, 12 (07) : A428 - A429
12345